 |
 |
Below is a list of previous ALZET promotions and names for the corresponding winners. Congratulations to the lucky winners, and thank you to all scientists who participated in these special ALZET promotions:
ALZET Pharmacology Newsletter Announcement 2009: The winner of the iPod is Mary Beth Moreno
ALZET Bibliography Update Mailer 2008: The winner of the iPod is Dr. John Salig
The Endocrine Society's 90th Annual Meeting 2008: The winner of the iPod is Dr. Rishita Tiwari from Baystate Medical College
American Association for Cancer Research 2008: The winner of the iPod is Dr. Nalin S. Siriwardhana
Experimental Biology 2008: The winner of the iPod is Dr. Philip R. Brauer from Creighton University School of Medicine
Society for Toxicology 2008: The winner of the iPod is Dr. Michael C. Savides from Ricerca Biosciences
Product News
ALZET
introduces new pump model (2006)
Available Now
Model 2006 Nominal Specifications:
-
Volume: 200 µl
-
Release rate: 0.15 µl/hour
-
Duration: 6 weeks
Key features:
-
Longest duration pump in any size, ideal for chronic studies in mice, rats, and other animal models
-
Low flow rate, ideal for tissue perfusion
ALZET introduces new pump model (1004)
Model 1004 Nominal Specifications:
-
Volume: 100 µl
-
Release rate: 0.11 µl/hour
-
Duration: 4 weeks
Key features:
-
Longest duration pump in 100 µl size; ideal for chronic studies in small mice and young rats
-
Slowest flow rate in ALZET product line, ideal for tissue perfusion
ALZET Osmotic Pumps Celebrate 30 Years of Continuous Delivery
Introduced in 1977, this year marks 30 years since the first ALZET Osmotic Pump was sold. Over the last three decades the ALZET pumps have been proven as an integral research tool, allowing for the continuous delivery of test compounds.
ALZET introduces three new specialized catheters.
These catheters are fully compatible with the ALZET Osmotic Pumps and are constructed from biocompatible materials. See more information on our catheter page. The various models include the following:
-
Rat Intrathecal Catheter - Short
-
Mouse Jugular - Adjustable Length
-
Mouse Jugular - Adjustable Length/Large Tip
Company News
6/10/2008
Pain Therapeutics and King Pharmaceuticals Announce Submission of New Drug Application for Remoxy. Remoxy and other opioid painkillers developed under this alliance are unique formulations of the patented Oradur technology licensed from Durect Corporation.
7/17/2007
DURECT Reports Positive Results from POSIDUR(TM) Phase IIb Hernia Trial, Triggering $8 million Milestone Payment from Nycomed
Latest Research Using ALZET Pumps
Local chemotherapy in the rat brainstem with multiple catheters: a feasibility study. Childs Nerv Syst 2009; 25(1):21-28. Thomale U et al.
Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression. J Biol Chem 2008; 283(23):15845-15852. Wang HY et al.
Pub Med Link
Steroid hormones act
transsynaptically within the Forebrain to regulate neuronal phenotype
and song stereotypy. JOURNAL OF NEUROSCIENCE 2007; 27(44):12045-12057.
>>> Meitzen J, et al.
PubMed
Link
Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model. Cancer Letters 2007; 247(1):143-149. >>> Zhang X, Connolly C, et al. "Continuous administration of 3TSR reduced dosage and improved therapeutic potency."
Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazoloquinazolines as Selective Inhibitors of Aurora B Kinase. J Med Chem 2007. >>> Mortlock AA, Foote KM, Heron NM, Jung FH, Pasquet G, Lohmann JJ et al.
Evaluation of an osmotic pump for microdialysis sampling in an awake and untethered rat. J Neurosci Methods 2007; 160(2):269-275. >>> Cooper JD, Heppert KE, Davies MI, Lunte SM. "the osmotic pump can be an invaluable improvement over the syringe pump.".
